What are the 5 most common causes of Interstitial Lung Disease (ILD) and their incidence rates?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

The 5 Most Common Causes of Interstitial Lung Disease and Their Incidence Rates

The five most common causes of interstitial lung disease (ILD) are idiopathic pulmonary fibrosis (55% of idiopathic interstitial pneumonias), connective tissue disease-associated ILD (25% of all ILD cases), hypersensitivity pneumonitis (15% of all ILD cases), sarcoidosis, and pneumoconioses. 1, 2

1. Idiopathic Pulmonary Fibrosis (IPF)

  • Incidence rate: 31.5 per 100,000 in men and 26.1 per 100,000 in women 3
  • Accounts for approximately one-third of all ILD cases 2
  • Accounts for 55% of all idiopathic interstitial pneumonias 1
  • Characterized by usual interstitial pneumonia (UIP) pattern on HRCT or lung biopsy 3
  • Predominantly affects older adults with average age of 60 ± 11 years 4
  • Male to female ratio is approximately equal 4

2. Connective Tissue Disease-Associated ILD (CTD-ILD)

  • Incidence rate: Accounts for 25% of all ILD cases 2
  • Average age of onset: 46 ± 17 years 4
  • Equal gender distribution 4
  • Rheumatoid arthritis is the most common underlying CTD causing ILD 4
  • CTD-ILDs represent a substantial subset accounting for almost 20% of all ILDs 3
  • Systemic sclerosis-related ILD (SSc-ILD) and rheumatoid arthritis-related ILD (RA-ILD) account for approximately 31% and 39% of CTD-ILDs, respectively 3

3. Hypersensitivity Pneumonitis (HP)

  • Incidence rate: Accounts for 15% of all ILD cases 2
  • Average age of onset: 53 ± 8.1 years 4
  • Equal gender distribution 4
  • Associated with exposure to organic antigens 3
  • Can present in acute, subacute, or chronic forms 3
  • Characterized by lymphocytic cellular pattern (>50% lymphocytes) on bronchoalveolar lavage 3

4. Sarcoidosis

  • Incidence rate: Specific incidence not provided in the evidence, but recognized as one of the most common ILDs 3
  • Female predominance 4
  • Often presents with normal pulmonary function tests 4
  • Characterized by non-caseating granulomas 3
  • CD4+/CD8+ ratio >4 on BAL is highly specific for sarcoidosis 3

5. Pneumoconioses

  • Incidence rate: Specific incidence not provided in the evidence, but recognized as one of the common ILDs 3
  • Male predominance 4
  • Often presents with normal pulmonary function tests 4
  • Associated with occupational exposure to inorganic dusts 3
  • Includes conditions such as silicosis, asbestosis, and coal worker's pneumoconiosis 3

Clinical Considerations

  • The overall prevalence of clinically significant ILD ranges from 25 to 74 per 100,000 population 3
  • In the US, ILD affects approximately 650,000 people and causes approximately 25,000 to 30,000 deaths per year 2
  • The overall mortality rate for ILD is approximately 12.1% 4
  • Diagnosis often requires a multidisciplinary approach involving HRCT, pulmonary function tests, bronchoalveolar lavage, and sometimes surgical lung biopsy 1
  • Treatment approaches vary significantly based on ILD classification, with predominantly inflammatory ILDs treated with immunosuppressive therapy and predominantly fibrotic ILDs treated with antifibrotic drugs 1

Diagnostic Pitfalls

  • Approximately 10-25% of ILD cases remain unclassifiable even after multidisciplinary discussion 1
  • Up to 10% of patients with ILD may have normal chest radiograph findings, so a normal CXR cannot rule out clinically significant disease 3
  • Multiple ILD pathologies may coexist in the same patient when multiple regions of the lung are biopsied 3
  • Certain lung pathology patterns occur in multiple ILD subtypes and thus are not disease-specific 3

Understanding the relative frequency of these conditions helps guide diagnostic approaches and treatment decisions for patients presenting with interstitial lung abnormalities.

References

Guideline

Interstitial Lung Disease Classification and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical features of interstitial lung diseases.

The Korean journal of internal medicine, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.